FULL: Buprenorphine Induction Low-Dose to Depot (BUILD2depot): development of safe rapid transfer to depot medication and Go/NoGo testing potential of remote community-based monitoring.

Project: Research

Project Details

AcronymBUILD2
StatusActive
Effective start/end date1/08/2024 → 31/07/2027

Collaborative partners

  • King's College London (lead)
  • Camurus AB
  • Q2i
  • Derbyshire Healthcare NHS Foundation Trust
  • South London and Maudsley NHS Foundation Trust

Funding

  • NIHR National Institute For Health & Care Research: £1,645,833.20